Cargando…

Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice

INTRODUCTION: Ataxia-telangiectasia is an autosomal-recessive disease that affects neuro-immunological functions, associated with increased susceptibility to malignancy, chromosomal instability and hypersensitivity to ionizing radiation. Although ataxia-telangiectasia mutated (ATM) heterozygous defi...

Descripción completa

Detalles Bibliográficos
Autores principales: Umesako, Seiichi, Fujisawa, Kae, Iiga, Sayoko, Mori, Nobuko, Takahashi, Masahiro, Hong, Doo-Pyo, Song, Chang-Woo, Haga, Satomi, Imai, Syunsuke, Niwa, Otsura, Okumoto, Masaaki
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064114/
https://www.ncbi.nlm.nih.gov/pubmed/15642165
http://dx.doi.org/10.1186/bcr968
_version_ 1782123293931732992
author Umesako, Seiichi
Fujisawa, Kae
Iiga, Sayoko
Mori, Nobuko
Takahashi, Masahiro
Hong, Doo-Pyo
Song, Chang-Woo
Haga, Satomi
Imai, Syunsuke
Niwa, Otsura
Okumoto, Masaaki
author_facet Umesako, Seiichi
Fujisawa, Kae
Iiga, Sayoko
Mori, Nobuko
Takahashi, Masahiro
Hong, Doo-Pyo
Song, Chang-Woo
Haga, Satomi
Imai, Syunsuke
Niwa, Otsura
Okumoto, Masaaki
author_sort Umesako, Seiichi
collection PubMed
description INTRODUCTION: Ataxia-telangiectasia is an autosomal-recessive disease that affects neuro-immunological functions, associated with increased susceptibility to malignancy, chromosomal instability and hypersensitivity to ionizing radiation. Although ataxia-telangiectasia mutated (ATM) heterozygous deficiency has been proposed to increase susceptibility to breast cancer, some studies have not found excess risk. In experimental animals, increased susceptibility to breast cancer is not observed in the Atm heterozygous deficient mice (Atm(+/-)) carrying a knockout null allele. In order to determine the effect of Atm heterozygous deficiency on mammary tumourigenesis, we generated a series of Atm(+/- )mice on the p53(+/- )background with a certain predisposition to spontaneous development of mammary carcinomas, and we examined the development of the tumours after X-irradiation. METHODS: BALB/cHeA-p53(+/- )mice were crossed with MSM/Ms-Atm(+/- )mice, and females of the F(1 )progeny ([BALB/cHeA × MSM/Ms]F(1)) with four genotypes were used in the experiments. The mice were exposed to X-rays (5 Gy; 0.5 Gy/min) at age 5 weeks. RESULTS: We tested the effect of haploinsufficiency of the Atm gene on mammary tumourigenesis after X-irradiation in the p53(+/- )mice of the BALB/cHeA × MSM/Ms background. The singly heterozygous p53(+/- )mice subjected to X-irradiation developed mammary carcinomas at around 25 weeks of age, and the final incidence of mammary carcinomas at 39 weeks was 31% (19 out of 61). The introduction of the heterozygous Atm knockout alleles into the background of the p53(+/- )genotype significantly increased the incidence of mammary carcinoma to 58% (32 out of 55) and increased the average number of mammary carcinomas per mouse. However, introduction of Atm alleles did not change the latency of development of mammary carcinoma. CONCLUSION: Our results indicate a strong enhancement in mammary carcinogenesis by Atm heterozygous deficiency in p53(+/- )mice. Thus, doubly heterozygous mice represent a useful model system with which to analyze the interaction of heterozygous genotypes for p53, Atm and other genes, and their effects on mammary carcinogenesis.
format Text
id pubmed-1064114
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-10641142005-03-11 Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice Umesako, Seiichi Fujisawa, Kae Iiga, Sayoko Mori, Nobuko Takahashi, Masahiro Hong, Doo-Pyo Song, Chang-Woo Haga, Satomi Imai, Syunsuke Niwa, Otsura Okumoto, Masaaki Breast Cancer Res Research Article INTRODUCTION: Ataxia-telangiectasia is an autosomal-recessive disease that affects neuro-immunological functions, associated with increased susceptibility to malignancy, chromosomal instability and hypersensitivity to ionizing radiation. Although ataxia-telangiectasia mutated (ATM) heterozygous deficiency has been proposed to increase susceptibility to breast cancer, some studies have not found excess risk. In experimental animals, increased susceptibility to breast cancer is not observed in the Atm heterozygous deficient mice (Atm(+/-)) carrying a knockout null allele. In order to determine the effect of Atm heterozygous deficiency on mammary tumourigenesis, we generated a series of Atm(+/- )mice on the p53(+/- )background with a certain predisposition to spontaneous development of mammary carcinomas, and we examined the development of the tumours after X-irradiation. METHODS: BALB/cHeA-p53(+/- )mice were crossed with MSM/Ms-Atm(+/- )mice, and females of the F(1 )progeny ([BALB/cHeA × MSM/Ms]F(1)) with four genotypes were used in the experiments. The mice were exposed to X-rays (5 Gy; 0.5 Gy/min) at age 5 weeks. RESULTS: We tested the effect of haploinsufficiency of the Atm gene on mammary tumourigenesis after X-irradiation in the p53(+/- )mice of the BALB/cHeA × MSM/Ms background. The singly heterozygous p53(+/- )mice subjected to X-irradiation developed mammary carcinomas at around 25 weeks of age, and the final incidence of mammary carcinomas at 39 weeks was 31% (19 out of 61). The introduction of the heterozygous Atm knockout alleles into the background of the p53(+/- )genotype significantly increased the incidence of mammary carcinoma to 58% (32 out of 55) and increased the average number of mammary carcinomas per mouse. However, introduction of Atm alleles did not change the latency of development of mammary carcinoma. CONCLUSION: Our results indicate a strong enhancement in mammary carcinogenesis by Atm heterozygous deficiency in p53(+/- )mice. Thus, doubly heterozygous mice represent a useful model system with which to analyze the interaction of heterozygous genotypes for p53, Atm and other genes, and their effects on mammary carcinogenesis. BioMed Central 2005 2004-12-10 /pmc/articles/PMC1064114/ /pubmed/15642165 http://dx.doi.org/10.1186/bcr968 Text en Copyright © 2004 Umesako et al., licensee BioMed Central Ltd.
spellingShingle Research Article
Umesako, Seiichi
Fujisawa, Kae
Iiga, Sayoko
Mori, Nobuko
Takahashi, Masahiro
Hong, Doo-Pyo
Song, Chang-Woo
Haga, Satomi
Imai, Syunsuke
Niwa, Otsura
Okumoto, Masaaki
Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice
title Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice
title_full Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice
title_fullStr Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice
title_full_unstemmed Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice
title_short Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice
title_sort atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064114/
https://www.ncbi.nlm.nih.gov/pubmed/15642165
http://dx.doi.org/10.1186/bcr968
work_keys_str_mv AT umesakoseiichi atmheterozygousdeficiencyenhancesdevelopmentofmammarycarcinomasinp53heterozygousknockoutmice
AT fujisawakae atmheterozygousdeficiencyenhancesdevelopmentofmammarycarcinomasinp53heterozygousknockoutmice
AT iigasayoko atmheterozygousdeficiencyenhancesdevelopmentofmammarycarcinomasinp53heterozygousknockoutmice
AT morinobuko atmheterozygousdeficiencyenhancesdevelopmentofmammarycarcinomasinp53heterozygousknockoutmice
AT takahashimasahiro atmheterozygousdeficiencyenhancesdevelopmentofmammarycarcinomasinp53heterozygousknockoutmice
AT hongdoopyo atmheterozygousdeficiencyenhancesdevelopmentofmammarycarcinomasinp53heterozygousknockoutmice
AT songchangwoo atmheterozygousdeficiencyenhancesdevelopmentofmammarycarcinomasinp53heterozygousknockoutmice
AT hagasatomi atmheterozygousdeficiencyenhancesdevelopmentofmammarycarcinomasinp53heterozygousknockoutmice
AT imaisyunsuke atmheterozygousdeficiencyenhancesdevelopmentofmammarycarcinomasinp53heterozygousknockoutmice
AT niwaotsura atmheterozygousdeficiencyenhancesdevelopmentofmammarycarcinomasinp53heterozygousknockoutmice
AT okumotomasaaki atmheterozygousdeficiencyenhancesdevelopmentofmammarycarcinomasinp53heterozygousknockoutmice